Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Revenue (2018 - 2025)

Historic Revenue for X4 Pharmaceuticals (XFOR) over the last 6 years, with Q3 2025 value amounting to $1.8 million.

  • X4 Pharmaceuticals' Revenue rose 21517.86% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.0 million, marking a year-over-year increase of 292956.37%. This contributed to the annual value of $2.6 million for FY2024, which is N/A changed from last year.
  • Per X4 Pharmaceuticals' latest filing, its Revenue stood at $1.8 million for Q3 2025, which was up 21517.86% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Revenue registered a high of $28.8 million during Q1 2025, and its lowest value of -$1.1 million during Q4 2022.
  • In the last 4 years, X4 Pharmaceuticals' Revenue had a median value of $560000.0 in 2024 and averaged $2.7 million.
  • In the last 5 years, X4 Pharmaceuticals' Revenue crashed by 2146.77% in 2023 and then soared by 25044.4% in 2025.
  • Quarter analysis of 4 years shows X4 Pharmaceuticals' Revenue stood at -$1.1 million in 2022, then grew by 3.06% to -$1.1 million in 2023, then soared by 233.18% to $1.5 million in 2024, then rose by 19.5% to $1.8 million in 2025.
  • Its last three reported values are $1.8 million in Q3 2025, $2.0 million for Q2 2025, and $28.8 million during Q1 2025.